BackModerna Overview

Moderna Inventory

Moderna's inventory is $310M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$313.00M
↓ 5.72% YoYΔ $-19.00M vs prior year quarter

Peer trimmed avg / median

Loading

Moderna Inventory History

Loading

Moderna vs. peers: Inventory Comparison

Loading

Moderna Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Moderna (MRNA) FAQ

Moderna (MRNA) currently reports a inventory of $310M as of September 2026. That compares with $330M in the prior-year period — down 5.7% year over year. Use the charts on this page to explore Moderna's inventory history and peer comparisons.

Moderna's inventory decreased from $330M to $310M — a 5.7% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Moderna reported $310M in inventory as of September 2026. That compares with $330M in the prior-year period — down 5.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $310M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Moderna, and consider following MRNA for alerts when major investors trade the stock.

Moderna is classified in the Healthcare sector. On inventory, it currently shows $310M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MRNA with unrelated industries.